
New York, August 28, 2026, 12:48 — Investors pulled $22.33 billion from U.S. equity funds as significant withdrawals from large-cap funds surpassed smaller gains seen in small-cap allocations.
The biggest equity outflow in five months was concentrated in the market’s largest companies.
Bond inflows replaced about 32% of net equity redemptions. This is rotation, not a full flight to cash.
Weekly positioning did not predict Friday’s ranking: small-cap fund inflows coexisted with IWM’s largest decline among these four exposures.
Bull case: earnings strength pulls capital back into large caps.
Bear case: persistent inflation pressures stocks and bonds together.
Confirmation: another week of large-cap outflows alongside mid/small inflows.
Sources: LSEG Lipper via Reuters, Federal Reserve, U.S. market quotes. Fund flows cover the week ended Aug. 26, 2026. ETF prices and volumes are timestamped Aug. 28, 2026, approximately 12:28 p.m. EDT.
SCHD's 2026 rotation is backed by exceptional flows. The next decision is whether a second ETF adds genuine diversification or only a new concentration.
Total return snapshots, including distributions; source dates vary from August 14–21.
Demand is unusually large relative to SCHD's asset base.
SCHD's YTD inflows equal roughly one-sixth of its August 14 asset base. That supports liquidity and price, but raises crowding risk.
Sector weights from Schwab, June 30.
Consensus for major holdings, not a rating on SCHD. August 24 snapshots.
| Holding | Weight | View | Target upside |
|---|---|---|---|
| Merck | 4.88% | BUY | −1.81% |
| Abbott | 4.83% | BUY | +2.51% |
| Amgen | 4.81% | BUY | −12.37% |
| Coca-Cola | 4.22% | BUY | +3.26% |
| Home Depot | 4.05% | BUY | +11.95% |
Average price targets show limited support across four of five leaders. Sources: StockAnalysis analyst pages; weights from Schwab, August 19.
The signal is positive; the margin of safety is thinner.
Investors rotated toward dividends, cash flow and lower multiples. $17.68 billion of YTD inflows reinforced that demand.
QQQ fills SCHD's 9.2% technology gap most directly. SPY offers broader balance with less style concentration.
A technology rebound, higher bond yields or weaker health and energy holdings could reverse SCHD's relative lead.
Use a second ETF to solve a documented exposure gap. Do not chase the dividend label alone: SCHD is near its high, top-ten holdings represent 41.4%, and analyst targets are mixed beneath the Buy headlines.
Sources: Schwab Asset Management, StockAnalysis, and ETF Central pages for SCHD, QQQ, SPY and VYM.
The catalysts most likely to move markets.
Policy tone can move rates, USD, equities, gold and crypto simultaneously.
A weak final reading or elevated inflation expectations could pressure risk assets.
A surprise versus 58.0 may alter the near-term manufacturing-growth narrative.